Phospho-Chk2 (Ser516) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Phospho-Chk2 (Ser516) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPhospho-Chk2 (Ser516)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, monkey
Isotypen/a
Formatimmunogen affinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB); ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionPolyclonal antibody to detect endogenous levels of Chk2 (pS516) in human and monkey samples. Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest; activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation; phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A; CDC25B and CDC25C; inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progress
ImmunogenImmunogen: Synthesized peptide derived from human Chk2 around the phosphorylation site of S516
Other Names[Serine/threonine-protein kinase Chk2; CHK2 checkpoint homolog; Cds1 homolog; Hucds1; hCds1; Checkpoint kinase 2; CHEK2], [CHEK2]
Gene, Accession #[Chk2], Gene ID: 11200, NCBI: NP_001005735.1, UniProt: O96017
Catalog #MBS846142
Price$335
Order / More InfoPhospho-Chk2 (Ser516) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.